Navigation Links
Timothy Cote, MD, MPH, Joins NORD as Chief Medical Officer
Date:7/19/2011

WASHINGTON, July 19, 2011 /PRNewswire-USNewswire/ -- Timothy R. Cote, MD, MPH, has joined the National Organization for Rare Disorders (NORD) as Chief Medical Officer.  Cote was formerly Director of the Office of Orphan Products Development at the U.S. Food and Drug Administration (FDA).

(Photo: http://photos.prnewswire.com/prnh/20110719/DC37656-a)

(Logo: http://photos.prnewswire.com/prnh/20110719/DC37656LOGO-b)

His role at NORD will be to provide medical guidance in all areas -- particularly advocacy and education -- to promote fair, compassionate public policies; encourage the development of safe, effective treatments; and increase awareness of rare diseases and the needs of patients and their families.

"Dr. Cote's extensive experience in orphan product development will help NORD represent the nearly 30 million Americans with rare diseases even more effectively," said Peter L. Saltonstall, NORD President and CEO.  "Our single biggest challenge at this time is that there is no treatment for most patients with rare diseases.  With Dr. Cote's help, NORD will be able to serve as an even stronger catalyst for the development of safe, effective treatments and ensuring patient access to them."

Since 1983, NORD has been the primary voice of the rare disease patient community in the U.S.  It provides advocacy, education and patient services on behalf of all rare disease patients and families.  Issues currently being addressed by NORD include the need for more rare disease education in the nation's medical schools, greater patient access to treatments and increased emphasis on rare disease research.  

From 2007 to May 2011, Dr. Cote served as Director of the FDA Office of Orphan Products Development (OOPD).  That office is FDA's primary interface with companies seeking orphan designation for drug and device products or seeking guidance in navigating FDA processes in reviewing orphan products.  As Director of OOPD, Dr. Cote was one of FDA's most visible spokespeople on issues related to orphan product development and also served as one of the agency's chief liaisons with patient organizations.

Before joining FDA, Dr. Cote was affiliated with the Centers for Disease Control and Prevention (CDC), serving as Country Director for Rwanda.  In that role, he was responsible for scientific and administrative leadership in patient care and research initiatives, and directed programs in HIV/AIDS, malaria and avian influenza.

Dr. Cote has also served as Senior Federal Advisor to the Director, District of Columbia Department of Health; Branch Chief, Therapeutics and Blood Safety, FDA Center for Biologics Evaluation and Research (CBER); and Medical Director, Cancer Statistics Branch, National Cancer Institute.

Dr. Cote holds a B.A. from Syracuse University, M.P.H. from Harvard School of Public Health, and M.D. from Howard University College of Medicine.

In addition to his role at NORD, he will serve on the faculty of the Keck Graduate Institute, a specialized graduate school in Claremont, California.


'/>"/>
SOURCE National Organization for Rare Disorders (NORD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer
2. WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors
3. Timothy T. Goodnow, Ph.D., Joins Sensors for Medicine and Science, Inc. Board of Directors
4. Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care
5. HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
6. INTENSA Medical Furniture Joins Attainia
7. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
8. Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers
9. Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
10. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
11. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
Breaking Medicine News(10 mins):